The effect of bioactive compound supplementation on obesity treatment

Phase 1

Recruiting

• Conditions: Obesity; Fatty liver; Diabetes mellitus; Hypertension; Insulin Resistance; C18.654.726.500; C06.552.241; C14.907.489; C18.452.394.750; C18.452.394.968.500

• Registration Number: RBR-22pqs9
• Lead Sponsor: Flávia Campos Corgosinho

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-12-17
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Obese women with BMI above 40kg / m² between 20 and 59 years of age.

Exclusion Criteria

Presence of acute inflammatory diseases; infectious diseases; neoplastic diseases; genetic syndromes; present age under 20 years; chronic consumption of vitamin supplements; alcohol (> 30g / day) (SBD, 2017); illicit drugs; do not live in the metropolitan region of goiania; swallowing problems and presenting any kind of intolerance or allergies to food supplement sources.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Infiltration of macrophages and morphology of adipocytes in the visceral and subcutaneous adipose tissue: evaluated by immunohistochemistry and the size of the adipocytes will be analyzed as well as the concentration of macrophages by area